卵巣腺癌の英語

肺癌、大腸癌、膵臓癌、胃癌、卵巣癌、子宮頸癌、乳癌及び前立腺癌、特に乳癌の治療における、DNA鎖切断（又は切断部）の修復を仲介する酵素の活性を阻害する薬剤。例文帳に追加

The agent that inhibits the activity of an enzyme that mediates repair of a DNA strand break is used for treatment of lung cancer, colon cancer, pancreatic cancer, stomach cancer, ovary cancer, cervical cancer, breast cancer and prostate cancer, particularly, of breast cancer. - 特許庁

上記抗体およびそのフラグメントを利用した、増加したIGF-I受容体を発現する腫瘍、例えば乳癌、大腸癌、肺癌、前立腺癌、卵巣癌、滑膜癌、骨肉腫および膵癌の治療。例文帳に追加

The antibodies and fragments thereof may be used in the treatment of tumors that express elevated levels of IGF-I receptor, such as breast cancer, colon cancer, lung cancer, ovarian carcinoma, synovial sarcoma, prostate cancer, and pancreatic cancer. - 特許庁

乳房、前立腺および卵巣の癌の予測のための、Ｓｈｃタンパク質に関連する方法および組成物例文帳に追加

METHOD AND COMPOSITION RELEVANT TO SHC PROTEIN FOR PREDICTING CANCERS OF BREAST, PROSTATE AND OVARY - 特許庁

本発明は、ある態様において、癌である又はその疑いのある患者において、肺癌、副腎癌、黒色腫、結腸癌、結腸直腸癌、卵巣癌、前立腺癌、肝臓癌、皮下癌、腸癌、肝細胞癌、網膜芽腫、子宮けい癌を検出し、かつ、部位を特定する方法を提供する。例文帳に追加

To provide a method for detecting and locating lung cancer, adrenal cancer, melanoma, colon cancer, colorectal cancer, ovarian cancer, prostate cancer, liver cancer, subcutaneous cancer, intestinal cancer, hepatocellular carcinoma, retinoblastoma, cervical cancer in subject that has or is suspected of having cancer in one embodiment. - 特許庁

特に、ＣＣＩ−７７９は、腎臓癌、軟部組織癌、乳癌、肺の神経内分泌性腫瘍、子宮頚癌、子宮癌、頭頚部癌、神経膠芽細胞腫、非小細胞肺癌、前立腺癌、膵臓癌、リンパ腫、黒色腫、小細胞肺癌、卵巣癌または結腸癌の治療に有用である。例文帳に追加

In particular, CCI-779 is useful for the treatment of renal cancers, soft tissue tumors, breast cancers, neuroendocrine tumors of lungs, cancers of cervix, cancers of uterus, head and neck cancers, neuroblastomas, non-small cell lung cancers, prostatic cancers, pancreatic cancers, lymphomas, melanomas, small cell lung cancers, ovarian cancers or colon cancers. - 特許庁

前立腺特異的でアンドロゲン制御される細胞膜結合型の分泌セリンプロテアーゼに由来する、またはそれに基づく、膀胱癌、肺癌、卵巣癌、および腎臓癌の診断および治療のための組成物を提供する。例文帳に追加

To provide compositions for the diagnosis and therapy of bladder, lung, ovary, and kidney cancers, derived from or based on a normally prostate-specific, androgen-regulated, cell membrane associated secreted serine protease. - 特許庁

新規な腫瘍マーカーを提供することであり、１）脳腫瘍、２）胆管癌、３）胆のう癌、４）卵巣癌、５）腎癌、６）膵癌、７）肺腺癌、８）肺大細胞癌、９）肺扁平上皮癌、１０）肺少細胞癌の適切な診断マーカーを提供すること。例文帳に追加

To provide a new appropriate tumor marker for: 1) brain tumor, 2) bile duct cancer, 3) gallbradder cancer, 4) ovarian cancer, 5) kidney cancer, 6) pancreatic cancer, 7) lung glandular cancer, 8) large cell lung cancer, 9) squamous epithelial cancer, and 10) small cell lung cancer. - 特許庁

疾患の例は癌、例えば肺、乳房、結腸、前立腺、膵臓、肺、肝臓、甲状腺、腎臓、脳、精巣、胃、消化管、腸、脊髄、洞、膀胱、尿路および卵巣の癌である。例文帳に追加

Examples of diseases are cancer such as lung, breast, colon, prostate, pancreas, lung, liver, thyroid, kidney, brain, testes, stomach, alimentary tract, intestine, bowel, spinal cord, sinuses, bladder, urinary tract or ovaries cancers. - 特許庁